Tandem Diabetes Care Inc TNDM

Morningstar Rating
$44.08 −0.56 (1.25%)
View Full Chart

Company Report

Price vs Fair Value

TNDM is trading at a 233% premium.
Price
$44.08
Fair Value
$39.00
Uncertainty
Very High
1-Star Price
$49.70
5-Star Price
$97.00
Economic Moat
Kjr
Capital Allocation
Nzsvrzx

Bulls Say, Bears Say

Bulls

Tandem’s t:slim X2 features a low-profile, color touchscreen that is very user-friendly for patients new to insulin pumps.

Bears

Medtronic arguably enjoys more accurate and advanced algorithms thanks to its far larger patient user base and proprietary data—a major reason why it remains a step ahead of Tandem in closing the loop.

News

Trading Information

Previous Close Price
$44.64
Day Range
$42.5945.03
52-Week Range
$13.8253.69
Bid/Ask
$44.08 / $45.75
Market Cap
$2.89 Bil
Volume/Avg
1.4 Mil / 1.5 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.61
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
2,400

Competitors

Valuation

Metric
TNDM
PODD
DXCM
Price/Earnings (Normalized)
69.4538.59
Price/Book Value
12.3316.5311.12
Price/Sales
3.619.497.22
Price/Cash Flow
44.6731.57
Price/Earnings
TNDM
PODD
DXCM

Financial Strength

Metric
TNDM
PODD
DXCM
Quick Ratio
2.292.412.39
Current Ratio
3.053.602.82
Interest Coverage
−14.277.0335.33
Quick Ratio
TNDM
PODD
DXCM

Profitability

Metric
TNDM
PODD
DXCM
Return on Assets (Normalized)
−12.16%9.03%10.74%
Return on Equity (Normalized)
−40.00%31.74%31.84%
Return on Invested Capital (Normalized)
−15.47%11.10%12.04%
Return on Assets
TNDM
PODD
DXCM

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
KvkdlxrkWrtdz$196.1 Bil
Stryker Corp
SYK
KjzrrrskrBkc$137.7 Bil
Boston Scientific Corp
BSX
KgccxmjwmHbtrjkv$122.3 Bil
Medtronic PLC
MDT
QsgbctddPppxkn$114.7 Bil
Edwards Lifesciences Corp
EW
BcwglcjpPqfvzk$39.6 Bil
Koninklijke Philips NV ADR
PHG
VmhwHfg$29.3 Bil
DexCom Inc
DXCM
PwpbzknlwHnfjw$27.1 Bil
Steris PLC
STE
SqmzhwzwVhvzs$23.3 Bil
Zimmer Biomet Holdings Inc
ZBH
KygktzkycfSqy$21.9 Bil
Insulet Corp
PODD
WdmybrjcvKjlvm$16.5 Bil

Sponsor Center